Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Chihiro Tohda, Rie Nakada, Takuya Urano, Akira Okonogi & Tomoharu Kuboyama. (2011) Kamikihi-to (KKT) Rescues Axonal and Synaptic Degeneration Associated with Memory Impairment in a Mouse Model of Alzheimer's Disease, 5XFAD. International Journal of Neuroscience 121:12, pages 641-648.
Read now
Read now
Articles from other publishers (22)
Gaurav Singh. 2023. Plants for Immunity and Conservation Strategies. Plants for Immunity and Conservation Strategies
87
96
.
Ashish Kumar, Arpita Konar, Sukant Garg, Sunil C. Kaul & Renu Wadhwa. (2021) Experimental evidence and mechanism of action of some popular neuro-nutraceutical herbs. Neurochemistry International 149, pages 105124.
Crossref
Crossref
Pradoldej Sompol, Jenna L. Gollihue, Susan D. Kraner, Irina A. Artiushin, Ryan A. Cloyd, Emad A. Chishti, Shon A. Koren, Grant K. Nation, Jose F. Abisambra, Orsolya Huzian, Lajos I. Nagy, Miklos Santha, Laszlo HacklerJrJr, Laszlo G. Puskas & Christopher M. Norris. (2021) Q134R: Small chemical compound with NFAT inhibitory properties improves behavioral performance and synapse function in mouse models of amyloid pathology. Aging Cell 20:7.
Crossref
Crossref
Chihiro Tohda, Chisato Kogure, Kaori Nomoto, Andreia de Toledo, Ximeng Yang & Eiichi Hirano. (2021) A Novel Heptapeptide, GPPGPAG Transfers to the Brain, and Ameliorates Memory Dysfunction and Dendritic Atrophy in Alzheimer’s Disease Model Mice. Frontiers in Pharmacology 12.
Crossref
Crossref
Md. Abdul Hannan, Raju Dash, Md. Nazmul Haque, Sung Min Choi & Il Soo Moon. (2020)
Integrated System Pharmacology and In Silico Analysis Elucidating Neuropharmacological Actions of
Withania somnifera
in the Treatment of Alzheimer’s Disease
. CNS & Neurological Disorders - Drug Targets 19:7, pages 541-556.
Crossref
Crossref
Mai M. Farid, Ximeng Yang, Tomoharu Kuboyama & Chihiro Tohda. (2020) Trigonelline recovers memory function in Alzheimer’s disease model mice: evidence of brain penetration and target molecule. Scientific Reports 10:1.
Crossref
Crossref
Tomoharu Kuboyama, Ximeng Yang & Chihiro Tohda. (2020) Natural Medicines and Their Underlying Mechanisms of Prevention and Recovery from Amyloid Β-Induced Axonal Degeneration in Alzheimer’s Disease. International Journal of Molecular Sciences 21:13, pages 4665.
Crossref
Crossref
Qin Xiang Ng, Wayren Loke, Nadine Xinhui Foo, Weng Jun Tan, Hwei Wuen Chan, Donovan Yutong Lim & Wee Song Yeo. (2019)
A systematic review of the clinical use of
Withania somnifera
(Ashwagandha) to ameliorate cognitive dysfunction
. Phytotherapy Research 34:3, pages 583-590.
Crossref
Crossref
N. S. Nikolaeva, A. V. Maltsev, R. K. Ovchinnikov, V. B. Sokolov, A. Yu. Aksinenko, E. V. Bovina & A. S. Kinzirsky. (2019) The Study of Cognitive-Stimulating Activity of Fluorinated Tetrahydrocarbazole Derivatives and Behavioral Responses in Transgenic Tg6799 Mice with Alzheimer’s Disease. Biology Bulletin 46:3, pages 268-276.
Crossref
Crossref
Samantha D. Creighton, Ari L. Mendell, Daniel Palmer, Bettina E. Kalisch, Neil J. MacLusky, Vania F. Prado, Marco A. M. Prado & Boyer D. Winters. (2019) Dissociable cognitive impairments in two strains of transgenic Alzheimer’s disease mice revealed by a battery of object-based tests. Scientific Reports 9:1.
Crossref
Crossref
Tomoharu Kuboyama, Keisuke Hirotsu, Tetsuya Arai, Hiroo Yamasaki & Chihiro Tohda. (2017) Polygalae Radix Extract Prevents Axonal Degeneration and Memory Deficits in a Transgenic Mouse Model of Alzheimer’s Disease. Frontiers in Pharmacology 8.
Crossref
Crossref
Gurcharan Kaur, Taranjeet Kaur, Muskan Gupta & Shaffi Manchanda. 2017. Science of Ashwagandha: Preventive and Therapeutic Potentials. Science of Ashwagandha: Preventive and Therapeutic Potentials
417
436
.
Kallol Dutta, Vivek Swarup & Jean-Pierre Julien. 2017. Science of Ashwagandha: Preventive and Therapeutic Potentials. Science of Ashwagandha: Preventive and Therapeutic Potentials
389
415
.
K. N. Roy Chengappa, Jessica M. Gannon, Luna Acharya & Abhishek Rai. 2017. Science of Ashwagandha: Preventive and Therapeutic Potentials. Science of Ashwagandha: Preventive and Therapeutic Potentials
345
371
.
Chihiro Tohda. (2016) New Age Therapy for Alzheimer’s Disease by Neuronal Network Reconstruction. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 39:10, pages 1569-1575.
Crossref
Crossref
Peter T. White, Chitra Subramanian, Hashim F. Motiwala & Mark S. Cohen. 2016. Anti-inflammatory Nutraceuticals and Chronic Diseases. Anti-inflammatory Nutraceuticals and Chronic Diseases
329
373
.
Tomoharu Kuboyama, Young-A. Lee, Hiroaki Nishiko & Chihiro Tohda. (2015) Inhibition of clathrin-mediated endocytosis prevents amyloid β-induced axonal damage. Neurobiology of Aging 36:5, pages 1808-1819.
Crossref
Crossref
Woo-Hyun Cho, Jung-Cheol Park, Dong-Hee Kim, Min-Su Kim, Sun-Young Lee, Hanbyeol Park, Jae-Hoon Kang, Seung-Woo Yeon & Jung-Soo Han. (2014) ID1201, the ethanolic extract of the fruit of Melia toosendan ameliorates impairments in spatial learning and reduces levels of amyloid beta in 5XFAD mice. Neuroscience Letters 583, pages 170-175.
Crossref
Crossref
T. J. Flanigan, Y. Xue, S. Kishan Rao, A. Dhanushkodi & M. P. McDonald. (2014) Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics. Genes, Brain and Behavior 13:5, pages 488-500.
Crossref
Crossref
Chaoyun Li, Azadeh Ebrahimi & Hermann Schluesener. (2013) Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease. Ageing Research Reviews 12:1, pages 116-140.
Crossref
Crossref
Chihiro Tohda, Takuya Urano, Masahito Umezaki, Ilka Nemere & Tomoharu Kuboyama. (2012) Diosgenin is an exogenous activator of 1,25D3-MARRS/Pdia3/ERp57 and improves Alzheimer's disease pathologies in 5XFAD mice. Scientific Reports 2:1.
Crossref
Crossref
Kenji Sugimoto, Kosuke Tamura, Naoki Ohta, Chihiro Tohda, Naoki Toyooka, Hideo Nemoto & Yuji Matsuya. (2012) Synthesis of dihydrofuran-fused perhydrophenanthrenes having a phenolic hydroxyl group as a novel anti-Alzheimer’s disease agent. Bioorganic & Medicinal Chemistry Letters 22:1, pages 449-452.
Crossref
Crossref